Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

B&L/Warburg Pincus merger

This article was originally published in The Tan Sheet

Executive Summary

Bausch & Lomb shareholders voted to approve the proposed merger with affiliates of Warburg Pincus LLC at a meeting of shareholders Sept. 21, the firm announces. According to the merger agreement, at closing, each outstanding share of common and Class B stock of Bausch & Lomb will be cancelled and converted into the right to receive $65 in cash, without interest. Affiliates of Warburg Pincus are not required to consummate the deal until after a 20-day "marketing period" following the shareholder vote. Subject to customary closing conditions, the firms expect the transaction to close early in the third quarter. In July, Advanced Medical Optics restated an earlier acquisition offer for Bausch & Lomb of $75 per share (1"The Tan Sheet" July 30, 2007, In Brief)...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS100921

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel